Want to join the conversation?
$MYL, which competes with $PFE, $JNJ and $GSK, said that R&D expense for 4Q15 and full-year 2015 rose due to the impact of the acquired EPD business and the continued development of respiratory, insulin and biologics programs. Adjusted SG&A was approx. 20% of total adjusted revenues for 4Q15 and 2015, which includes the impact of the EPD business.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.